Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments, page-165

First 165 Last

Share
Profile

Follow
Sparkz918

1,049 Posts.

241

27/04/20

11:32

Post #: 44275632
Share

Originally posted by Spectre888: ↑

They have dispelled using Hydrochloroquine based primarily on the severe side effects. There are, as yet, no approved drugs for treating COVID-19. We all know this. The FDA is an administrative body for approving drugs and medications not for researching potential treatments.

You stated: "(Also, we treat Quinine and Quinine-like drugs like Hydroxychloroquine the same class of drug (same family). i.e. we health professional don't give a dam whether it's botantical or synthetic. Ask your doctor or pharmacist if you are confused about the two."So what you are saying is that you don't care about patient side effects? That's concerning.

https://www.drugs.com/sfx/quinine-side-effects.html (Quinine sulfate not Quinine compound from the bark of the cinchona tree)
https://www.drugs.com/sfx/hydroxychloroquine-side-effects.html

Expand

In Australia, health professionals use Australian Medicine Handbook for drug info. (www.drugs.com is considered as unreliable source in the eye of health professionals)

According to Australian Medicine Handbook 2020, Quinine can cause "intravascular haemolysis, acute renal failure, prolonged QT interval, photosensitivity". It specifically mentions "quinine may prolong the QT interval and increase the risk of arrhythmia"

Let's go for evidence based practice and stop using unreliable/biased information please!!

MXC Price at posting: 2.9¢ Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

Top Stories

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

MIN

Ellison slapped with $20M sanction from MinRes but will stay on as leader – for now

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

MIN

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

There are more pages in this discussion • 13 more messages in this thread...

First 165 Last

Add RGT (ASX) to my watchlist

(20min delay)
Last 28.0¢		Change -0.030(9.68%)		Mkt cap ! $15.19M

Open	High	Low	Value	Volume
25.5¢	28.0¢	25.5¢	$986	3.534K

Buyers (Bids)

No.	Vol.	Price($)
1	49	28.0¢

Sellers (Offers)

Price($)	Vol.	No.
30.0¢	1141	1

View Market Depth

No.	Vol.	Price($)
1	49	0.280
1	3920	0.255
2	6004	0.250
1	3988	0.245
1	12900	0.240

Price($)	Vol.	No.
0.300	1141	1
0.305	2073	2
0.310	12050	2
0.320	50	1
0.330	105	1

Last trade - 13.22pm 04/11/2024 (20 minute delay)

RGT (ASX) Chart

Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments, page-165

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Ellison slapped with $20M sanction from MinRes but will stay on as leader – for now

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: MGC Pharma Signs Agreement Targeting Anti-Viral Treatments, page-165

Top Stories

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Ellison slapped with $20M sanction from MinRes but will stay on as leader – for now

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%

Movers and Shakers: Zip Co, MinRes, Kuniko, more – The week's top ASX gainers

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News